source
- FDA Requests Public Feedback on Designing Early-Phase Trials for Psychedelic Drug IbogaineThe U.S. Food and Drug Administration announced it is seeking comments from the public on how to structure early-phase clinical studies of ibogaine, a plant-derived psychoactive compound. The agen…
- Australia's TGA begins five-year transition to new medicine labeling standardsThe Therapeutic Goods Administration has adopted two new labeling standards for medicines in Australia. The standards will become mandatory after a five-year transition period that starts now. Ph…